Antiretroviral nanoparticles: An extended drug delivery modality

Christopher J. Destache, Michael Goede, Todd Belgum

Research output: Contribution to journalArticlepeer-review


The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.

Original languageEnglish (US)
Pages (from-to)383-386
Number of pages4
JournalTherapeutic delivery
Issue number3
StatePublished - Sep 2010

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science


Dive into the research topics of 'Antiretroviral nanoparticles: An extended drug delivery modality'. Together they form a unique fingerprint.

Cite this